Will the FDA’s regulatory policies, particularly for rare-disease drugs, shift in the wake of Vinay Prasad’s imminent departure?
Source
Stat News
Opens original article in a new tab
Democrats are outlining a new vision for the health care system ahead of the midterms.
(MedPage Today) -- "Little-known virus spreading rapidly on West Coast, experts warn..." was the opening line of an Instagram post quoting Fox News that I read last week. Fair enough, I thought. But then came the scaremongering. "Cold, flu and...
A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval.
(MedPage Today) -- Medicare coverage of targeted disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA) -- both under Medicare Advantage and in separate Part D plans -- is likely to leave many patients wanting, researchers...